1 January 2024 false No description of principal activity Taxfiler 2024.6 13072839business:PrivateLimitedCompanyLtd2024-01-012024-12-31 130728392023-12-31 130728392024-01-012024-12-31 13072839business:AuditExemptWithAccountantsReport2024-01-012024-12-31 13072839business:FilletedAccounts2024-01-012024-12-31 130728392024-12-31 130728392023-12-31 13072839core:WithinOneYear2024-12-31 13072839core:WithinOneYear2023-12-31 13072839core:AfterOneYear2024-12-31 13072839core:AfterOneYear2023-12-31 13072839core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 13072839core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 13072839core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 13072839core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 13072839core:PreviouslyStatedAmount2024-12-31 13072839core:PreviouslyStatedAmount2023-12-31 13072839business:SmallEntities2024-01-012024-12-31 13072839business:Director12024-01-012024-12-31 13072839countries:EnglandWales2024-01-012024-12-31 13072839business:RegisteredOffice2024-01-012024-12-31 13072839core:LandBuildings2024-01-012024-12-31 13072839core:PlantMachinery2024-01-012024-12-31 13072839core:FurnitureFittings2024-01-012024-12-31 13072839core:ComputerEquipment2024-01-012024-12-31 13072839core:LandBuildings2023-12-31 13072839core:PlantMachinery2023-12-31 13072839core:FurnitureFittings2023-12-31 13072839core:ComputerEquipment2023-12-31 13072839core:LandBuildings2024-12-31 13072839core:PlantMachinery2024-12-31 13072839core:FurnitureFittings2024-12-31 13072839core:ComputerEquipment2024-12-31 130728392023-01-012023-12-31 iso4217:GBP xbrli:pure
Company Registration No. 13072839 (England and Wales)
Calita Nutraceuticals Ltd Unaudited accounts for the year ended 31 December 2024
Calita Nutraceuticals Ltd Unaudited accounts Contents
Page
- 2 -
Calita Nutraceuticals Ltd Statement of financial position as at 31 December 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
97,566 
168,650 
Current assets
Inventories
254,524 
282,483 
Debtors
219,843 
247,216 
Cash at bank and in hand
25,735 
62,499 
500,102 
592,198 
Creditors: amounts falling due within one year
(302,385)
(408,197)
Net current assets
197,717 
184,001 
Total assets less current liabilities
295,283 
352,651 
Creditors: amounts falling due after more than one year
(1,141,129)
(990,964)
Provisions for liabilities
Deferred tax
(2,781)
(31,795)
Net liabilities
(848,627)
(670,108)
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
(848,727)
(670,208)
Shareholders' funds
(848,627)
(670,108)
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 30 September 2025 and were signed on its behalf by
Alka Agarwal Director Company Registration No. 13072839
- 3 -
Calita Nutraceuticals Ltd Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
Calita Nutraceuticals Ltd is a private company, limited by shares, registered in England and Wales, registration number 13072839. The registered office is Unit 1B, Great Central Industrial Estate, Great Central Way, Rugby, CV21 3XH.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Land & buildings
Over the term of the lease
Plant & machinery
Straight line over 3 years
Fixtures & fittings
Straight line over 3 years
Computer equipment
Straight line over 3 years
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Pension costs
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
- 4 -
Calita Nutraceuticals Ltd Notes to the Accounts for the year ended 31 December 2024
Government grants
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
4
Tangible fixed assets
Land & buildings 
Plant & machinery 
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At cost 
At cost 
At 1 January 2024
117,266 
257,778 
31,074 
4,645 
410,763 
Additions
- 
- 
2,748 
- 
2,748 
At 31 December 2024
117,266 
257,778 
33,822 
4,645 
413,511 
Depreciation
At 1 January 2024
27,397 
195,608 
17,310 
1,798 
242,113 
Charge for the year
13,128 
51,040 
8,322 
1,342 
73,832 
At 31 December 2024
40,525 
246,648 
25,632 
3,140 
315,945 
Net book value
At 31 December 2024
76,741 
11,130 
8,190 
1,505 
97,566 
At 31 December 2023
89,869 
62,170 
13,764 
2,847 
168,650 
5
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Trade debtors
184,519 
209,979 
Accrued income and prepayments
8,156 
7,638 
Other debtors
27,168 
29,599 
219,843 
247,216 
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
VAT
19,895 
22,277 
Trade creditors
254,079 
355,799 
Taxes and social security
10,746 
12,788 
Accruals
17,665 
17,333 
302,385 
408,197 
7
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Other creditors
813,129 
662,964 
Loans from directors
328,000 
328,000 
1,141,129 
990,964 
- 5 -
Calita Nutraceuticals Ltd Notes to the Accounts for the year ended 31 December 2024
8
Transactions with related parties
During the year, Life On Health Care Ltd, a Company connected to Mrs Agarwal, loaned £40,000 (2023: £175,000) to the Company. This loan and previous loans are being charged at 8%. Interest of £50,164, has been charged to the profit and loss account in the year. At the balance sheet date, the Company owed Life On Health Care Ltd, £753,128 (2023: £662,964).
9
Average number of employees
During the year the average number of employees was 36 (2023: 36).
- 6 -